KDR and breast cancer: In orthotopic breast cancer models of 4T1 and EMT6 and the MMTV-PyMT model of spontaneous breast cancer, high-dose anti-VEGFR2 treatment was found to cause resistance to VEGFR2 monoclonal antibody and VEGFR2-TKI.